Most prominently, the combination of BTKi and BCL2 has been effective in CLL, MCL and MZL and is being tested in R/R FL (NCT02956382) [72,73,74,75]. This evidence concerns the gene BCL2 and B-cell chronic lymphocytic leukemia.